Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Expert Opinion on Pharmacotherapy|June 17, 2009
The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalaprilChristos Chatzikyrkou, Hermann Haller, Jan Menne
Clinical Nephrology. Case Studies|October 19, 2017
Thromboembolism in renal transplant artery due to atrial fibrillationJanina Müller-Deile, Anke Schwarz, Jan Menne
Contributions to Nephrology|August 25, 2006
Insulin resistance and renal diseaseDanilo Fliser, Jan T Kielstein, Jan Menne
Current Opinion in Nephrology and Hypertension|December 3, 2015
Monocyte chemoattractant protein-1 and the kidneyHermann Haller, Anna Bertram, Felix Nadrowitz, et al.
Current Hypertension Reports|April 27, 2016
Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?Hermann Haller, Anna Bertram, Klaus Stahl, et al.
European Radiology|June 21, 2022
Risk of acute kidney injury after contrast-enhanced computerized tomography: a systematic review and meta-analysis of 21 propensity score-matched cohort studiesMikal Obed, Maria Magdalena Gabriel, Eva Dumann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2012
Resistant hypertension: baroreflex stimulation as a new toolJan Menne, Jens Jordan, Silvia Linnenweber-Held, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 10, 2019
Pretransplant dialysis modality and long-term patient and kidney allograft outcome: a 15-year retrospective single-centre cohort studyMichael S Balzer, Stephanie Pankow, Robert Claus, et al.
Biomed Research International|October 31, 2017
Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate-Free Radical Scavenger and Growth Factor InhibitionHermann Haller, Linong Ji, Klaus Stahl, et al.
Blood Pressure|February 9, 2026
Long-Term Efficacy and Safety of First- and Second-Generation Baroreflex Activation Devices in Refractory Hypertension: A Single Center Retrospective AnalysisJessica Kaufeld, Ruha Younes, Thomas Aper, et al.
Pageof 10